In food allergy, omalizumab may also exert its protective effect through the formation of allergen‐specific circulating IgE‐IgG complexes, which compete with cell‐bound IgE for epitopes on allergen surface, thus disrupting IgE receptor aggregation.10, 11, 12. The gene discussed is IGHE; the disease is food allergy.